We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Routine Blood Glucose Value Correlates with Diabetes Risk

By LabMedica International staff writers
Posted on 22 Mar 2015
Print article
Image: UniCel DxC 800 Synchron Clinical Systems (Photo courtesy of Beckman Coulter).
Image: UniCel DxC 800 Synchron Clinical Systems (Photo courtesy of Beckman Coulter).
Random glucose values obtained during routine blood tests are often overlooked, but could provide valuable insight into whether someone is at risk for having type 2 diabetes.

Random Blood Glucose (RBG) values in which the clinician is unaware of when the patient last ate account for the majority of glucose tests in clinical practice. Current guidelines do not call for using RBG values as a screening test for diabetes and do not consider higher levels an indicator of diabetes risk.

Scientists at the University of Texas Southwestern Medical Center (Dallas, TX, USA) analyzed data from 13,792 participants in the 2005-2010 National Health and Nutrition Examination Surveys, which tested participants for diabetes as part of the survey. The investigators examined the association between random blood glucose and a patient's diabetes status in patients without diagnosed diabetes. The study population consisted of non-pregnant adults, age18 and older.

Serum RBG measurements were determined using the Beckman Oxygen electrode, glucose oxidase method. Between 2007and 2012, one instrument change occurred as from 2008 the Beckman Unicel CxC800 Synchron (Beckman Coulter; Brea, CA, USA) was used. HbA1C assays were conducted using high-performance liquid chromatography (HPLC) methods mainly on the Tosoh HbA1C G7 (Tosoh Bioscience, Inc.; South San Francisco, CA, USA). Diabetes was defined as having an HbA1C ≥ 6.5% (48 mmol/mol) and prediabetes as having an HbA1C of 5.7–6.4% (39–46mmol/mol). Dysglycemia was defined as having an HbA1C ≥ 5.7% (39 mmol/mol).

The team found that those with even modest elevations in random blood glucose (RBG), between 100 to 119 mg/dL, were seven-times more likely to have diabetes, according to the study. As that number rose, so did the risk. Those with RBG values of 120 to 139 mg/dL were 30-times as likely to have undiagnosed diabetes. Individuals with values under 100 mg/dL served as a reference point and were not considered at risk.

Michael E. Bowen, MD, MPH, an assistant professor of Internal Medicine and lead author, said, “Our results provide compelling evidence that a single, elevated random blood glucose value is a strong risk factor for diabetes. After adjusting for traditional diabetes risk factors, we found that individuals with a single random glucose value greater than or equal to 100 mg/dL were 20-times more likely to have undiagnosed diabetes compared with those whose values were less than 100 mg/dL. We shouldn't ignore these values. If we do, we are missing an opportunity to identify patients at high risk for diabetes.” The study was published on February 4, 2015, in the Journal of Clinical Endocrinology and Metabolism.

Related Links:
University of Texas Southwestern Medical Center
Beckman Coulter 
Tosoh Bioscience 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Molecular Diagnostics

view channel
Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

Renal cell carcinomas (RCCs) are notably diverse, encompassing over 20 distinct subtypes and generally categorized into clear cell and non-clear cell types; around 20% of all RCCs fall into the non-clear... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more